Drug intelligence / Profile preview

Compound Digestive Enzyme Capsules

Development stage
Unknown
Lead developer
Changzhou Qianhong Biopharma
Modality
Recombinant Proteins and Enzymes, Small Molecules
Administration
Oral
01

Overview

Compound Digestive Enzyme Capsules is an oral pharmaceutical preparation developed and marketed by Changzhou Qianhong Biopharma for the treatment of indigestion and digestive disorders. The formulation is a combination of several active ingredients: pepsin, pancreatin (containing amylase, lipase, and protease), cellulase, and ursodeoxycholic acid (UDCA). These components work together to supplement endogenous digestive enzymes and bile acids, facilitating the breakdown of proteins, carbohydrates, fats, and plant fibers. Specifically, pepsin and pancreatin proteases degrade proteins, amylase breaks down starches, lipase hydrolyzes fats, and cellulase decomposes cellulose. Ursodeoxycholic acid acts as a choleretic, increasing bile secretion and improving fat emulsification. This product is commonly used to alleviate symptoms such as bloating, loss of appetite, and postprandial discomfort associated with enzyme deficiency or hepatobiliary dysfunction.

Brand names
Qianhong
Other names
复方消化酶胶囊Fufang Xiaohuamei Jiaonang
02

Targets

FXR (Farnesoid x-activated receptor)GPBAR1

Beyond the preview

Go deeper on Compound Digestive Enzyme Capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Compound Digestive Enzyme Capsules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call